Life Science Investing Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
Life Science Investing CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
Life Science Investing Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
Life Science Investing Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare's SRT Combined with Punch Excision to Treat Keloids
